Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.04 Million USD | 90.28% |
| 2022 | 9.48 Million USD | 25.25% |
| 2021 | 7.57 Million USD | 33.8% |
| 2020 | 5.65 Million USD | -0.14% |
| 2019 | 5.66 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 13.83 Million USD | 45.95% |
| 2023 FY | 18.04 Million USD | 90.28% |
| 2023 Q4 | 18.04 Million USD | 24.97% |
| 2023 Q3 | 14.43 Million USD | 14.61% |
| 2023 Q2 | 12.59 Million USD | -8.97% |
| 2022 Q3 | 14.66 Million USD | 124.79% |
| 2022 Q4 | 9.48 Million USD | -35.34% |
| 2022 FY | 9.48 Million USD | 25.25% |
| 2022 Q1 | 7.27 Million USD | -3.85% |
| 2022 Q2 | 6.52 Million USD | -10.38% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 7.57 Million USD | 33.8% |
| 2021 Q4 | 7.57 Million USD | 28.95% |
| 2021 Q3 | 5.87 Million USD | 0.0% |
| 2020 FY | 5.65 Million USD | -0.14% |
| 2020 Q4 | 5.65 Million USD | 0.0% |
| 2019 FY | 5.66 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 68.576% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 98.422% |
| Journey Medical Corporation | 76.84 Million USD | 76.521% |
| Dynavax Technologies Corporation | 997.09 Million USD | 98.19% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 91.233% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 97.523% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 98.854% |
| PainReform Ltd. | 9.93 Million USD | -81.703% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 46.611% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 34.022% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 34.022% |
| SCYNEXIS, Inc. | 128.41 Million USD | 85.949% |
| Silver Spike Investment Corp. | 88.57 Million USD | 79.63% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | 21.983% |
| Alpha Teknova, Inc. | 128.58 Million USD | 85.968% |
| Alvotech | 950.09 Million USD | 98.101% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 98.005% |
| Bright Green Corporation | 17.4 Million USD | -3.678% |
| Embecta Corp. | 1.21 Billion USD | 98.514% |
| Safety Shot Inc | 12.7 Million USD | -41.969% |
| Procaps Group, S.A. | 460.18 Million USD | 96.079% |
| Cosmos Health Inc. | 66.29 Million USD | 72.784% |
| Theratechnologies Inc. | 77.76 Million USD | 76.799% |
| Harrow Health, Inc. | 311.75 Million USD | 94.212% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -21.151% |
| Biofrontera Inc. | 27.93 Million USD | 35.404% |
| DURECT Corporation | 45.18 Million USD | 60.072% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 98.719% |
| Cronos Group Inc. | 1.13 Billion USD | 98.409% |
| OptiNose, Inc. | 107.72 Million USD | 83.251% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 96.17% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 67.751% |
| RedHill Biopharma Ltd. | 23.04 Million USD | 21.712% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 96.078% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -51.391% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 77.936% |
| Radius Health, Inc. | 1.71 Billion USD | 98.949% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 66.14% |
| ProPhase Labs, Inc. | 91.92 Million USD | 80.372% |
| Phibro Animal Health Corporation | 982.18 Million USD | 98.163% |
| Procaps Group S.A. | 460.18 Million USD | 96.079% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 58.339% |
| Viatris Inc. | 47.68 Billion USD | 99.962% |
| Rockwell Medical, Inc. | 52.17 Million USD | 65.417% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 84.722% |
| SIGA Technologies, Inc. | 254.83 Million USD | 92.92% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.584% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 93.408% |
| Shineco, Inc. | 84.17 Million USD | 78.566% |
| PetIQ, Inc. | 868.22 Million USD | 97.922% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -113.826% |
| Incannex Healthcare Limited | 17.04 Million USD | -5.843% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.445% |
| Alimera Sciences, Inc. | 153.52 Million USD | 88.247% |
| Assertio Holdings, Inc. | 286.41 Million USD | 93.7% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -203.157% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 42.249% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -36.199% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 93.09% |
| Talphera, Inc. | 20.39 Million USD | 11.532% |
| Alvotech | 950.09 Million USD | 98.101% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 95.558% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 98.907% |
| Currenc Group, Inc. | 141.49 Million USD | 87.248% |
| Kamada Ltd. | 351.96 Million USD | 94.874% |
| Indivior PLC | 1.95 Billion USD | 99.075% |
| Evoke Pharma, Inc. | 7.06 Million USD | -155.259% |
| Flora Growth Corp. | 23.62 Million USD | 23.63% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -36.199% |
| Evolus, Inc. | 188.99 Million USD | 90.453% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 98.59% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 98.807% |
| Akanda Corp. | 8.83 Million USD | -104.107% |